Cancer Center Administration undertakes a range of activities essential to maximizing the effectiveness of CCSG-supported infrastructure and adding value to the UC Davis cancer research enterprise and the integrated cancer program with the Lawrence Livermore National Laboratory (LLNL). Administration oversight of CCSG expenditures ensures that they are used only in the ways specified by NCI Guidelines and the proposal for competitive renewal of NCI designation. Activities encompass support for scientific programs and collaborations, membership, shared resources, developmental funds used for pilot studies, recruitment and developing shared resources, clinical trial data management, and leadership organizations. The Administration adds value to the cancer research effort by planning and organizing """"""""Cross Talk"""""""" meetings, cancer biology seminars, an annual research symposium, and various collaborative conferences targeting Initiatives In breast cancer, Inflammation, stem cells, Imaging, brain tumors, and key research communities at UC Davis and LLNL. In addition, Administration is responsible for the coordination of Cancer Center membership, the Cancer Center Web site (http://cancer.ucdmc.ucdavis.edu), and various list serves and communication tools. Central operations, fiscal affairs, contract and grant administration, purchasing, event planning, proposal development, and public affairs are other core services provided by Cancer Center Administration to the Director, senior leaders and to the membership at large to advance strategic plans, new areas of research, and team science.

Public Health Relevance

Administration maintains the research organization and data about the research organization, provides staff expertise in financial management, grant proposal development scientific meeting development internal and external relations of significance to the research enterprise, and modern forms of electronic communication such as list servers and the Internet. In these ways. It builds the scope of cancer research at UCD.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA093373-12
Application #
8743638
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
12
Fiscal Year
2014
Total Cost
$373,386
Indirect Cost
$130,120
Name
University of California Davis
Department
Type
DUNS #
047120084
City
Davis
State
CA
Country
United States
Zip Code
95618
Wang, Minan; Yao, Li-Chin; Cheng, Mingshan et al. (2018) Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy. FASEB J 32:1537-1549
York, D; Sproul, C D; Chikere, N et al. (2018) Expression and targeting of transcription factor ATF5 in dog gliomas. Vet Comp Oncol 16:102-107
Fletcher, Kyle; Klosterman, Steven J; Derevnina, Lida et al. (2018) Comparative genomics of downy mildews reveals potential adaptations to biotrophy. BMC Genomics 19:851
Wang, Fuli; Zhang, Hongyong; Ma, Ai-Hong et al. (2018) COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther 17:474-483
Yuan, Ye; He, Yixuan; Bo, Ruonan et al. (2018) A facile approach to fabricate self-assembled magnetic nanotheranostics for drug delivery and imaging. Nanoscale 10:21634-21639
Seo, Jai Woong; Tavaré, Richard; Mahakian, Lisa M et al. (2018) CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols. Clin Cancer Res 24:4976-4987
Xue, Xiangdong; Huang, Yee; Bo, Ruonan et al. (2018) Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment. Nat Commun 9:3653
Knight, Jennifer F; Sung, Vanessa Y C; Kuzmin, Elena et al. (2018) KIBRA (WWC1) Is a Metastasis Suppressor Gene Affected by Chromosome 5q Loss in Triple-Negative Breast Cancer. Cell Rep 22:3191-3205
Couto, K M; Moore, P F; Zwingenberger, A L et al. (2018) Clinical characteristics and outcome in dogs with small cell T-cell intestinal lymphoma. Vet Comp Oncol 16:337-343
Dou, John; Schmidt, Rebecca J; Benke, Kelly S et al. (2018) Cord blood buffy coat DNA methylation is comparable to whole cord blood methylation. Epigenetics 13:108-116

Showing the most recent 10 out of 836 publications